Skip to content

Clinical trials

Observational Melanoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Observational Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20161
20181
20202
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed3
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3
Chinese PLA General Hospital1
Novartis Pharmaceuticals1
OrienGene Biotechnology Ltd.1
Shanghai Junshi Bioscience Co., Ltd.1
Sun Yat-sen University1
The Affiliated Hospital of Qingdao University1
West China Hospital1
Xijing Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma11
Breast Neoplasms3
Head and Neck Neoplasms3
Colorectal Neoplasms2
Glioblastoma2
Lung Neoplasms2
Pancreatic Neoplasms2
Sarcoma2
Abdominal Neoplasms1
Basal Cell Carcinoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.